FR2826269B1 - Utilisation de polyammonium quaternaire dans le traitement de l'acne et des desordres cutanes lies a l'hyperseborrhee - Google Patents

Utilisation de polyammonium quaternaire dans le traitement de l'acne et des desordres cutanes lies a l'hyperseborrhee

Info

Publication number
FR2826269B1
FR2826269B1 FR0108283A FR0108283A FR2826269B1 FR 2826269 B1 FR2826269 B1 FR 2826269B1 FR 0108283 A FR0108283 A FR 0108283A FR 0108283 A FR0108283 A FR 0108283A FR 2826269 B1 FR2826269 B1 FR 2826269B1
Authority
FR
France
Prior art keywords
hyperseborrhea
acne
treatment
skin disorders
related skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0108283A
Other languages
English (en)
Other versions
FR2826269A1 (fr
Inventor
Herve Richard
Sylvie Cupferman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR0108283A priority Critical patent/FR2826269B1/fr
Priority to PCT/FR2002/001979 priority patent/WO2003000221A1/fr
Publication of FR2826269A1 publication Critical patent/FR2826269A1/fr
Application granted granted Critical
Publication of FR2826269B1 publication Critical patent/FR2826269B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/54—Polymers characterized by specific structures/properties
    • A61K2800/542—Polymers characterized by specific structures/properties characterized by the charge
    • A61K2800/5426—Polymers characterized by specific structures/properties characterized by the charge cationic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
FR0108283A 2001-06-22 2001-06-22 Utilisation de polyammonium quaternaire dans le traitement de l'acne et des desordres cutanes lies a l'hyperseborrhee Expired - Fee Related FR2826269B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0108283A FR2826269B1 (fr) 2001-06-22 2001-06-22 Utilisation de polyammonium quaternaire dans le traitement de l'acne et des desordres cutanes lies a l'hyperseborrhee
PCT/FR2002/001979 WO2003000221A1 (fr) 2001-06-22 2002-06-10 Utilisation de polyammonium quaternaire dans le traitement de l'acne et des desordres cutanes lies a l'hyperseborrhee

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0108283A FR2826269B1 (fr) 2001-06-22 2001-06-22 Utilisation de polyammonium quaternaire dans le traitement de l'acne et des desordres cutanes lies a l'hyperseborrhee

Publications (2)

Publication Number Publication Date
FR2826269A1 FR2826269A1 (fr) 2002-12-27
FR2826269B1 true FR2826269B1 (fr) 2003-09-26

Family

ID=8864676

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0108283A Expired - Fee Related FR2826269B1 (fr) 2001-06-22 2001-06-22 Utilisation de polyammonium quaternaire dans le traitement de l'acne et des desordres cutanes lies a l'hyperseborrhee

Country Status (2)

Country Link
FR (1) FR2826269B1 (fr)
WO (1) WO2003000221A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2918269B1 (fr) 2007-07-06 2016-11-25 Oreal Composition de protection solaire contenant l'association d'un polymere semi-cristallin et de particules de latex creuses.
FR2918561B1 (fr) 2007-07-09 2009-10-09 Oreal Utilisation pour la coloration de la peau de l'acide dehydroascorbique ou des derives polymeres ; procedes de soin et/ou de maquillage.
FR2918563B1 (fr) 2007-07-12 2009-12-04 Oreal Composition photoprotectrice fluide aqueuse a base d'un polymere polyamide a terminaison amide tertiaire.
US10016354B2 (en) 2011-03-23 2018-07-10 Basf Se Compositions containing polymeric, ionic compounds comprising imidazolium groups
EP3378313A1 (fr) 2011-03-23 2018-09-26 Basf Se Compositions contenant composés polymères ioniques comportant des groupes imidazolium
JP7203385B2 (ja) * 2017-04-18 2023-01-13 ナンヤン・テクノロジカル・ユニバーシティー 抗菌性ポリ（アルキル化イミダゾリウム）塩
CN111344333A (zh) * 2017-11-01 2020-06-26 新加坡科技研究局 作为新型抗细菌和抗真菌材料的咪唑*-季铵共聚物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303543A (en) * 1979-02-27 1981-12-01 The Procter & Gamble Company Method for cleansing and conditioning the skin
FR2763853B1 (fr) * 1997-05-28 2000-01-07 Oreal Association d'un retinoide avec un polymere polyamine

Also Published As

Publication number Publication date
FR2826269A1 (fr) 2002-12-27
WO2003000221A1 (fr) 2003-01-03

Similar Documents

Publication Publication Date Title
PT1083889E (pt) Compostos de tetra-hidronaftaleno e sua utilizacao no tratamento de doencas neurodegenerativas
IS2107B (is) Arýlsúlfónamíð og hliðstæður þeirra og notkun þeirra við meðhöndlun taugahrörnunarsjúkdóma
EP1767197A3 (fr) Trategies therapeutiques pour la prevention et le traitement de la maladie d'alzheimer
FR15C0089I2 (fr) Antagonistes de recombinaison de l'il-5 utiles dans le traitement des troubles induits par l'il-5
IL138732A0 (en) The use of polyamines in the treatment of dermatological symptoms
DK1047428T3 (da) Anvendelse af morpholinol til behandlingen af seksualforstyrrelser
EP1007048A4 (fr) Identification d'agents utiles dans le traitement de la maladie d'alzheimer
FR2854074B1 (fr) Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
FR2812197B1 (fr) Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches
AU2002335794A1 (en) Allylamides useful in the treatment of alzheimer's disease
NO20033443L (no) Anvendelse av CD-2-bindende midler ved behandling eller forebygging av hudlidelser
ID27576A (id) Penggunaan siklosporin dalam pengobatan penyakit-penyakit peradangan autoimun
IT1320860B1 (it) Apparecchiatura per il trattamento di disgregazione di campionibiologici e dispositivo disgregatore per l'impiego in detta
FR2768623B1 (fr) Composition cosmetique et/ou dermatologique a usage topique pour le traitement des peaux grasses
FR2826269B1 (fr) Utilisation de polyammonium quaternaire dans le traitement de l'acne et des desordres cutanes lies a l'hyperseborrhee
IL160018A0 (en) Isoxazolopyridinones and use thereof in the treatment of parkinson's disease
FR2717080B1 (fr) Utilisation de l'éliprodil et de ses énantiomères pour la préparation de médicaments utiles dans le traitement des neuropathies périphériques et des maladies neurodégénératives centrales.
AU2729400A (en) Application of a viral complement inhibitory protein in the treatment and diagnosis of alzheimer's disease
DE69528637D1 (de) Hautbehandlungsmittel gegen akne
ITMI20001216A0 (it) Impiego dell'aloe-emodin nel trattamento di patologie neoplastiche diorigine neuroectodermica
DZ3320A1 (fr) Complexe comprenant de l'eletriptane et de la sulphobutylether-cyclodextrine pour le traitement de la migraine
FR2792199B3 (fr) Utilisation de l'osanetant pour la preparation de medicaments utiles dans le traitement des troubles de l'humeur
FR2774596B1 (fr) Utilisation de composes selenies dans la prevention et le traitement de la maladie d'alzheimer
FR2828647B1 (fr) Maquillage-soin de la peau pour le traitement et la prevention du vieillissement
FR2710266B1 (fr) Nouvelles compositions en cosmétologie et dermatologie proposées dans le traitement des verrues.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20070228